arrow
Return

Decrease in plasma adiponectin concentrations in patients with variant angina pectoris

delete2006-01-01
delete21
delete
OA
AI
S
Soon Jun Hong
H
Hong Seog Seo
S
Seung‐Woon Rha
D
Dong Joo Oh
J
Jung Ah Kwon
J
Jang, YS
Y
Young Moo Ro
C
Chang Gyu Park
DOI:10.1253/circj.70.414delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and variant angina pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable angina pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6 +/- 5.4 vs 5.2 +/- 4.0 vs 9.0 +/- 6.2 mu g/ml, p < 0.001, respectively). Multivariate analysis indicated that plasma adiponectin (odds ratio (OR) 0.735, 95% confidence interval (CI) 0.621-0.855, p=0.011), smoking (OR 2.012, 95% CI 1.210-3.880, p=0.020), and age (OR 0.976, 95% CI 0.957-0.997, p=0.022) correlated independently with the development of VAP. Conclusions Our results suggest that a decrease in plasma adiponectin concentration might be associated with the development of VAP.
Keywords:
acetylcholine
acute coronary syndrome
adiponectin
variant angina
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

C
Circulation Journal
IF:
3.7
Papers:
8.3K
Citations:
1.0W

Organization

No organization information available
Cited Papers

Cited Papers

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway
err2000-09-12
err1.7K
errOAAI
errOuchi, N; Kihara, S; Arita, Y; Okamoto, Y; Maeda, K; Kuriyama, H; Hotta, K; Nishida, M; Takahashi, M; Muraguchi, M; Ohmoto, Y; Nakamura, T; Yamashita, S; Funahashi, T; Matsuzawa, Y
errShare
errSave
Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
err2001-02-27
err1.3K
errOAAI
errOuchi, N; Kihara, S; Arita, Y; Nishida, M; Matsuyama, A; Okamoto, Y; Ishigami, M; Kuriyama, H; Kishida, K; Nishizawa, H; Hotta, K; Muraguchi, M; Ohmoto, Y; Yamashita, S; Funahashi, T; Matsuzawa, Y
errShare
errSave
Role of adiponectin in preventing vascular stenosis - The missing link of adipo-vascular axis
err2002-10-01
err810
errOAAI
errMatsuda, M; Shimomura, I; Sata, M; Arita, Y; Nishida, M; Maeda, N; Kumada, M; Okamoto, Y; Nagaretani, H; Nishizawa, H; Kishida, K; Komuro, R; Ouchi, N; Kihara, S; Nagai, R; Funahashi, T; Matsuzawa, Y
errShare
errSave
Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension
err2004-01-01
err50
errOAAI
errAgata, J; Nagahara, D; Kinoshita, S; Takagawa, Y; Moniwa, N; Yoshida, D; Ura, N; Shimamoto, K
errShare
errSave
Decreased plasma adiponectin concentration in patients with essential hypertension
err2003-01-01
err389
errOAAI
errAdamczak, M; Wiecek, A; Funahashi, T; Chudek, J; Kokot, F; Matsuzawa, Y
errShare
errSave
Mammalian chromosome structure
err1993-06-01
err0
PREAI
errChris Tyler-Smith; Huntington F. Willard
errShare
errSave
Implications of plasma concentrations of adiponectin in patients with coronary artery disease
errHEART
IF4.4
err2004-05-01
err258
errOAAI
errNakamura, Y; Shimada, K; Fukuda, D; Shimada, Y; Ehara, S; Hirose, M; Kataoka, T; Kamimori, K; Shimodozono, S; Kobayashi, Y; Yoshiyama, M; Takeuchi, K; Yoshikawa, J
errShare
errSave
researcher View more